Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.35 |
| ▸ | MEN1 | O00255 | 3/20 | 0.34 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.34 |
| ▸ | MAPT | P10636 | 3/20 | 0.34 |
| ▸ | HPGD | P15428 | 3/20 | 0.34 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.34 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.33 |
| ▸ | LMNA | P02545 | 2/20 | 0.33 |
| ▸ | GPR55 | Q9Y2T6 | 1/20 | 0.33 |
| ▸ | CSF1R | P07333 | 1/20 | 0.33 |
| ▸ | PDGFRB | P09619 | 1/20 | 0.33 |
| ▸ | GSK3A | P49840 | 1/20 | 0.33 |
| ▸ | CDK9 | P50750 | 1/20 | 0.33 |
| ▸ | CDK5 | Q00535 | 1/20 | 0.33 |
| ▸ | ACVR1 | Q04771 | 1/20 | 0.33 |
| ▸ | CDK5R1 | Q15078 | 1/20 | 0.33 |
| ▸ | TAOK1 | Q7L7X3 | 1/20 | 0.33 |
| ▸ | DYRK1B | Q9Y463 | 1/20 | 0.33 |
| ▸ | GLA | P06280 | 1/20 | 0.33 |
| ▸ | KMO | O15229 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21881790 | 0.98 | GP6 (0.35) | L3MBTL1MEN1ALDH1A1MAPTHPGD | |
| SCHEMBL21881792 | 0.92 | MEN1 (0.41) | L3MBTL1MEN1ALDH1A1MAPTHPGD | |
| SCHEMBL21268707 | 0.90 | L3MBTL1 (0.44) | L3MBTL1MEN1ALDH1A1MAPTHPGD | |
| SCHEMBL20080923 | 0.90 | L3MBTL1 (0.44) | L3MBTL1MEN1ALDH1A1MAPTHPGD | |
| SCHEMBL18180999 | 0.88 | L3MBTL1 (0.42) | L3MBTL1MEN1ALDH1A1MAPTHPGD | |
| SCHEMBL18180975 | 0.88 | L3MBTL1 (0.42) | L3MBTL1MEN1ALDH1A1MAPTHPGD | |
| SCHEMBL31624102 | 0.88 | L3MBTL1 (0.42) | L3MBTL1MEN1ALDH1A1MAPTHPGD | |
| SCHEMBL29500541 | 0.88 | L3MBTL1 (0.42) | L3MBTL1MEN1ALDH1A1MAPTHPGD | |
| SCHEMBL19497364 | 0.87 | L3MBTL1 (0.41) | L3MBTL1MEN1ALDH1A1MAPTHPGD | |
| SCHEMBL20080954 | 0.87 | L3MBTL1 (0.41) | L3MBTL1MEN1ALDH1A1MAPTHPGD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11795186-B2 | Organic electronic device comprising an organic semiconductor layer and a device | NOVALED GMBH (DE) | 2023-10-24 | — | — | US | disclosed |
| US-11795186-B2 | Organic electronic device comprising an organic semiconductor layer and a device | NOVALED GMBH (DE) | 2023-10-24 | — | — | US | disclosed |
| US-20200161559-A1 | Organic Electronic Device Comprising an Organic Semiconductor Layer | NOVALED GMBH (DE) | 2020-05-21 | — | — | US | disclosed |
| US-20200095269-A1 | Organic Electronic Device Comprising an Organic Semiconductor Layer and a Device | NOVALED GMBH (DE) | 2020-03-26 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200095269-A1 | Organic Electronic Device Comprising an Organic Semiconductor Layer and a Device | C1S, C1R, CCNA1 | L3MBTL1 812/4885MEN1 762/4885ALDH1A1 887/4885 |
| US-11795186-B2 | Organic electronic device comprising an organic semiconductor layer and a device | C1S, C1R, CCNA1 | L3MBTL1 812/4885MEN1 762/4885ALDH1A1 887/4885 |
| US-20200161559-A1 | Organic Electronic Device Comprising an Organic Semiconductor Layer | C1S, YAP1, ESR1 | L3MBTL1 710/4885MEN1 715/4885ALDH1A1 1093/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.